Literature DB >> 29303605

Neonatal hypoglycemia, early-onset diabetes and hypopituitarism due to the mutation in EIF2S3 gene causing MEHMO syndrome.

J Stanik1, M Skopkova, D Stanikova, K Brennerova, L Barak, L Ticha, J Hornova, I Klimes, D Gasperikova.   

Abstract

Recently, the genetic cause of several syndromic forms of glycemia dysregulation has been described. One of them, MEHMO syndrome, is a rare X-linked syndrome recently linked to the EIF2S3 gene mutations. MEHMO is characterized by Mental retardation, Epilepsy, Hypogonadism/hypogenitalism, Microcephaly, and Obesity. Moreover, patients with MEHMO had also diabetes and endocrine phenotype, but detailed information is missing. We aimed to provide more details on the endocrine phenotype in two previously reported male probands with MEHMO carrying a frame-shift mutation (I465fs) in the EIF2S3 gene. Both probands had a neonatal hypoglycemia, early onset insulin-dependent diabetes, and hypopituitarism due to dysregulation and gradual decline of peptide hormone secretion. Based on the clinical course in our two probands and also in previously published patients, neonatal hypoglycemia followed by early-onset diabetes and hypopituitarism may be a consistent part of the MEHMO phenotype.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29303605     DOI: 10.33549/physiolres.933689

Source DB:  PubMed          Journal:  Physiol Res        ISSN: 0862-8408            Impact factor:   1.881


  10 in total

1.  Immunologic phenotype of a child with the MEHMO syndrome.

Authors:  I Trochanová; D Staníková; M Škopková; K Haštová; D Gašperíková; J Staník; P Čižnár
Journal:  Physiol Res       Date:  2020-09-09       Impact factor: 1.881

2.  Expanding the phenotype of the recurrent truncating eIF2γ pathogenic variant p.(Ile465Serfs*4) identified in two brothers with MEHMO syndrome.

Authors:  Sofia Ygberg; Anna Lindstrand
Journal:  Clin Case Rep       Date:  2022-06-19

3.  Eukaryotic initiation factor-2, gamma subunit, suppresses proliferation and regulates the cell cycle via the MAPK/ERK signaling pathway in acute myeloid leukemia.

Authors:  Jielun Lu; Shuyi Chen; Huo Tan; Zhenqian Huang; Bo Li; Ling Liu; Yimin Chen; Xiaozhen Zeng; Yawei Zou; Lihua Xu
Journal:  J Cancer Res Clin Oncol       Date:  2021-07-07       Impact factor: 4.553

Review 4.  The integrated stress response: From mechanism to disease.

Authors:  Mauro Costa-Mattioli; Peter Walter
Journal:  Science       Date:  2020-04-24       Impact factor: 47.728

5.  Impaired EIF2S3 function associated with a novel phenotype of X-linked hypopituitarism with glucose dysregulation.

Authors:  Louise C Gregory; Carolina B Ferreira; Sara K Young-Baird; Hywel J Williams; Magdalena Harakalova; Gijs van Haaften; Sofia A Rahman; Carles Gaston-Massuet; Daniel Kelberman; Waseem Qasim; Sally A Camper; Thomas E Dever; Pratik Shah; Iain C A F Robinson; Mehul T Dattani
Journal:  EBioMedicine       Date:  2019-03-14       Impact factor: 11.205

6.  MEHMO syndrome mutation EIF2S3-I259M impairs initiator Met-tRNAiMet binding to eukaryotic translation initiation factor eIF2.

Authors:  Sara K Young-Baird; Byung-Sik Shin; Thomas E Dever
Journal:  Nucleic Acids Res       Date:  2019-01-25       Impact factor: 19.160

7.  YIPF5 mutations cause neonatal diabetes and microcephaly through endoplasmic reticulum stress.

Authors:  Elisa De Franco; Maria Lytrivi; Hazem Ibrahim; Hossam Montaser; Matthew N Wakeling; Federica Fantuzzi; Kashyap Patel; Céline Demarez; Ying Cai; Mariana Igoillo-Esteve; Cristina Cosentino; Väinö Lithovius; Helena Vihinen; Eija Jokitalo; Thomas W Laver; Matthew B Johnson; Toshiaki Sawatani; Hadis Shakeri; Nathalie Pachera; Belma Haliloglu; Mehmet Nuri Ozbek; Edip Unal; Ruken Yıldırım; Tushar Godbole; Melek Yildiz; Banu Aydin; Angeline Bilheu; Ikuo Suzuki; Sarah E Flanagan; Pierre Vanderhaeghen; Valérie Senée; Cécile Julier; Piero Marchetti; Decio L Eizirik; Sian Ellard; Jonna Saarimäki-Vire; Timo Otonkoski; Miriam Cnop; Andrew T Hattersley
Journal:  J Clin Invest       Date:  2020-12-01       Impact factor: 14.808

Review 8.  Clinical implications of the glucokinase impaired function - GCK MODY today.

Authors:  J Hulín; M Škopková; T Valkovičová; S Mikulajová; M Rosoľanková; P Papcun; D Gašperíková; J Staník
Journal:  Physiol Res       Date:  2020-11-02       Impact factor: 1.881

9.  Novel pathogenic EIF2S3 missense variants causing clinically variable MEHMO syndrome with impaired eIF2γ translational function, and literature review.

Authors:  Urania Kotzaeridou; Sara K Young-Baird; Vanessa Suckow; Alexis G Thornburg; Matias Wagner; Inga Harting; Stine Christ; Tim Strom; Thomas E Dever; Vera M Kalscheuer
Journal:  Clin Genet       Date:  2020-09-04       Impact factor: 4.296

10.  Monogenic and syndromic diabetes due to endoplasmic reticulum stress.

Authors:  Stephen I Stone; Damien Abreu; Janet B McGill; Fumihiko Urano
Journal:  J Diabetes Complications       Date:  2020-05-08       Impact factor: 2.852

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.